| abstract |
The present invention relates to a new noradrenergic and specific serotonergic anxiolytic and antidepressant (NaSSA), and to a method for producing same and using same in the treatment of mental health disorders. The subject matter of the present invention is a new noradrenergic and specific serotonergic preparation for treating mental health disorders in people, which is 2,8 dimethyl-5-(2-phenylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride (AHCl), a polymorphic modification thereof, and methods for producing and using same. |